Mr. Zengjun Xu has resigned as a director of LakeShore Biopharma Co., Ltd, effective on June 14, 2024. Mr. Xu has advised that his resignation was due to personal reasons and not a result of any disagreement with the Company on any matter related to the operations, policies, or practices of the Company. The Company fully appreciates Ms. Wu and Mr. Xu?s service to the Company and the Board.

Following such resignation, the Board is now comprised of six members, including: (1) Mr. Dave Chenn, (2) Dr. Hui Shao (David), (3) Ms. Rachel Yu, (4) Mr. Adam Zhao, (5) Mr. Thomas Xue, and (6) Mr. Chunyang Shao.